1,169
Views
37
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Chronic Obstructive Pulmonary Disease in UK Primary Care: Incidence and Risk Factors

, , &
Pages 369-379 | Published online: 08 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Xiaofei Zhang, Hongru Chen, Kunfang Gu, Jiahao Chen & Xiubo Jiang. (2021) Association of Body Mass Index with Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:1, pages 101-113.
Read now
Chitra Lal & Akram Khan. (2020) Emerging Treatments for COPD: Evidence to Date on Revefenacin. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:1, pages 112-119.
Read now
Tuula Vasankari, Tommi Härkänen, Annette Kainu, Katri Sääksjärvi, Tiina Mattila, Pekka Jousilahti & Tarja Laitinen. (2019) Predictors of New Airway Obstruction – An 11 Year’s Population-Based Follow-Up Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:1, pages 45-50.
Read now
Ah Young Leem, Boram Park, Young Sam Kim, Ji Ye Jung & Sungho Won. (2018) Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 509-517.
Read now
Dionne CW Braeken, Gernot GU Rohde, Frits ME Franssen, Johanna HM Driessen, Tjeerd P van Staa, Patrick C Souverein, Emiel FM Wouters & Frank de Vries. (2017) Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2425-2432.
Read now
Eirini Mitsiki, Eleni Bania, Christos Varounis, Konstantinos I Gourgoulianis & Evangelos C Alexopoulos. (2015) Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1371-1382.
Read now
Catherine E Rycroft, Anne Heyes, Lee Lanza & Karin Becker. (2012) Epidemiology of chronic obstructive pulmonary disease: a literature review. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 457-494.
Read now

Articles from other publishers (30)

Jack L. Janetzki, Matthew J. Sykes, Michael B. Ward & Nicole L. Pratt. (2023) Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis. Drug Safety.
Crossref
Yunchao Wang, Ao Lin, Ruiqi He, Cuiyi Chen, Xiaobin Zeng, Yujie Pan, Chun Mao, Chenli Xie, Dongsheng Huang, Yibin Deng, Xuhui Zhang, Jiachun Lu & Xinhua Wang. (2023) The role of EPAS1 polymorphisms on COPD susceptibility in southern Chinese. Heliyon 9:10, pages e20226.
Crossref
Jack L. Janetzki, Nicole L. Pratt, Michael B. Ward & Matthew J. Sykes. (2023) Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of Glutathione Peroxidase 1 in Chronic Obstructive Pulmonary Disease. Pharmaceutical Research 40:6, pages 1553-1568.
Crossref
Hao Huang, Xueliang Huang, Jiaman Liao, Yushao Li, Yaoting Su, Yaxian Meng & Yiqiang Zhan. (2023) Sex-specific non-linear associations between body mass index and impaired pulmonary ventilation function in a community-based population: Longgang COPD study. Frontiers in Pharmacology 14.
Crossref
Adrian H Taylor, Tom P Thompson, Adam Streeter, Jade Chynoweth, Tristan Snowsill, Wendy Ingram, Michael Ussher, Paul Aveyard, Rachael L Murray, Tess Harris, Colin Green, Jane Horrell, Lynne Callaghan, Colin J Greaves, Lisa Price, Lucy Cartwright, Jonny Wilks, Sarah Campbell, Dan Preece & Siobhan Creanor. (2023) Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT. Health Technology Assessment 27:04, pages 1-277.
Crossref
Thu-Lan Kelly, Michael Ward, Nicole L. Pratt, Emmae Ramsay, Marianne Gillam & Elizabeth E. Roughead. (2022) The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians. Respiratory Research 23:1.
Crossref
David J. McCulley, Erik A. Jensen, Jennifer M. S. Sucre, Sarah McKenna, Laura G. Sherlock, Evgenia Dobrinskikh & Clyde J. Wright. (2022) Racing against time: leveraging preclinical models to understand pulmonary susceptibility to perinatal acetaminophen exposures. American Journal of Physiology-Lung Cellular and Molecular Physiology 323:1, pages L1-L13.
Crossref
Clyde J. Wright. (2021) Acetaminophen and the Developing Lung: Could There Be Lifelong Consequences?. The Journal of Pediatrics 235, pages 264-276.e1.
Crossref
Joanne T. Chang, Rafael Meza, David T. Levy, Douglas Arenberg & Jihyoun Jeon. (2021) Prediction of COPD risk accounting for time-varying smoking exposures. PLOS ONE 16:3, pages e0248535.
Crossref
Z. R. Aisanov, A. G. Chuchalin & E. N. Kalmanova. (2019) Chronic obstructive pulmonary disease and cardiovascular comorbidity. Kardiologiia 59:8S, pages 24-36.
Crossref
Youngmee Kim & Won-Kyung Cho. (2019) Factors affecting the development of airflow limitation among South Korean smokers. Tobacco Induced Diseases 17:March.
Crossref
Hye Jung Park, Min Kwang Byun, Chin Kook Rhee, Kyungjoo Kim, Hyung Jung Kim & Kwang-Ha Yoo. (2018) Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study. Respiratory Research 19:1.
Crossref
Sara Roversi, Leonardo M. Fabbri, Don D. Sin, Nathaniel M. Hawkins & Alvar Agustí. (2016) Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. American Journal of Respiratory and Critical Care Medicine 194:11, pages 1319-1336.
Crossref
Natalie Terzikhan, Katia M. C. Verhamme, Albert Hofman, Bruno H. Stricker, Guy G. Brusselle & Lies Lahousse. (2016) Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. European Journal of Epidemiology 31:8, pages 785-792.
Crossref
Leah Jayes, Patricia L. Haslam, Christina G. Gratziou, Pippa Powell, John Britton, Constantine Vardavas, Carlos Jimenez-Ruiz, Jo Leonardi-Bee, Bertrand Dautzenberg, Bo Lundbäck, Monica Fletcher, Archie Turnbull, Paraskevi Katsaounou, Dick Heederik, Dan Smyth, Sofia Ravara, Jean-Paul Sculier, Fernando Martin & Jose Ignacio De Grada Orive. (2016) SmokeHaz. Chest 150:1, pages 164-179.
Crossref
Nienke van Rein, Suzanne C. Cannegieter, Saskia le Cessie, Frits R. Rosendaal, Pieter H. Reitsma, Felix J. M. van der Meer & Willem M. Lijfering. (2016) Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects. American Journal of Epidemiology 183:10, pages 930-936.
Crossref
Martin Söderholm, Malin Inghammar, Bo Hedblad, Arne Egesten & Gunnar Engström. (2015) Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. European Journal of Epidemiology 31:2, pages 159-168.
Crossref
Lijie Wang, Yan Guan, Yan Li, Xiuju Liu, Yakun Zhang, Fuxia Wang, Lingling Kong & Qisen Guo. (2015) Asociación entre enfermedades respiratorias crónicas y Helicobacter pylori: un metaanálisis. Archivos de Bronconeumología 51:6, pages 273-278.
Crossref
Lijie Wang, Yan Guan, Yan Li, Xiuju Liu, Yakun Zhang, Fuxia Wang, Lingling Kong & Qisen Guo. (2015) Association Between Chronic Respiratory Diseases and Helicobacter pylori: A Meta-Analysis. Archivos de Bronconeumología (English Edition) 51:6, pages 273-278.
Crossref
Ana Filipa Macedo, Fiona Claire Taylor, Juan P Casas, Alma Adler, David Prieto-Merino & Shah Ebrahim. (2014) Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Medicine 12:1.
Crossref
Francisco García-Rio, Joan B. Soriano, Marc Miravitlles, Luis Muñoz, Enric Duran-Tauleria, Guadalupe Sánchez, Victor Sobradillo & Julio Ancochea. (2014) Impact of Obesity on the Clinical Profile of a Population-Based Sample with Chronic Obstructive Pulmonary Disease. PLoS ONE 9:8, pages e105220.
Crossref
Rihong Zhai, Xiaojin Yu, Yongyue Wei, Li Su & David C. Christiani. (2014) Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease. International Journal of Cancer 134:4, pages 961-970.
Crossref
Hana Müllerova, Alvar Agusti, Sebhat Erqou & Douglas W. Mapel. (2013) Cardiovascular Comorbidity in COPD. Chest 144:4, pages 1163-1178.
Crossref
Wim Timens, Hannie Sietsma & Joanne L. Wright. 2014. Spencer's Pathology of the Lung. Spencer's Pathology of the Lung 605 660 .
Eva Berggren Broström, Olof Akre, Miriam Katz-Salamon, David Jaraj & Magnus Kaijser. (2013) Obstructive pulmonary disease in old age among individuals born preterm. European Journal of Epidemiology 28:1, pages 79-85.
Crossref
Ana S.M. Afonso, Katia M.C. Verhamme, Miriam C.J.M. Sturkenboom & Guy G.O. Brusselle. (2011) COPD in the general population: Prevalence, incidence and survival. Respiratory Medicine 105:12, pages 1872-1884.
Crossref
Roberto de Marco, Simone Accordini, Alessandro Marcon, Isa Cerveri, Josep M. Antó, Thorarinn Gislason, Joachim Heinrich, Christer Janson, Deborah Jarvis, Nino Kuenzli, Bénédicte Leynaert, Jordi Sunyer, Cecilie Svanes, Matthias Wjst & Peter Burney. (2011) Risk Factors for Chronic Obstructive Pulmonary Disease in a European Cohort of Young Adults. American Journal of Respiratory and Critical Care Medicine 183:7, pages 891-897.
Crossref
Luis A. García Rodríguez, Mari-Ann Wallander, Elisa Martín-Merino & Saga Johansson. (2010) Heart failure, myocardial infarction, lung cancer and death in COPD patients: A UK primary care study. Respiratory Medicine 104:11, pages 1691-1699.
Crossref
Mária Posgay, Mihály János Varró, Renáta Szentmihályi & Zsolt Lang. (2010) Envitonmental epidemiological study on respiratory diseases in two Hungarian towns. Orvosi Hetilap 151:10, pages 378-384.
Crossref
Lionel A. Mandell & Robert C. Read. 2010. Antibiotic and Chemotherapy. Antibiotic and Chemotherapy 574 588 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.